Press Releases Profound Medical Corp.

Equities

PRN

CA74319B5027

Delayed Toronto S.E. Other stock markets 11:51:21 2024-05-13 am EDT			5-day change	1st Jan Change
10.54 ^CAD	-0.19%		+4.98%	-5.05%

May. 09	Profound Reports a Narrower First-Quarter Loss; Provides 2024 Revenue Guidance	MT
May. 09	Transcript : Profound Medical Corp., Q1 2024 Earnings Call, May 09, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance	May. 09	AQ
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum	May. 06	AQ
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow	Apr. 22	AQ
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 09	AQ
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 07	AQ
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference	Mar. 04	AQ
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	Feb. 27	AQ
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow	Feb. 15	AQ
Profound Medical Announces Non-Brokered Private Placement	Jan. 16	AQ
Rising Nanocap Stars of Medical Technology (TBRIF, PROF, VPTDF, ATBPF)	Jan. 04	AQ
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues	Jan. 03	AQ
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares	Dec. 27	AQ
Profound Medical Announces Proposed Public Offering of Common Shares	Dec. 27	AQ
Profound Medical to Participate in the Stifel 2023 Healthcare Conference	Nov. 08	AQ
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting	Nov. 03	AQ
Profound Medical Announces Third Quarter 2023 Financial Results	Nov. 02	AQ
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 Conference Call to Follow	23-10-20	AQ
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow	23-10-19	AQ
Profound Medical 2023 Virtual Analyst and Investor Day Agenda	23-10-11	AQ
Profound Medical 2023 Virtual Analyst & Investor Day Agenda	23-10-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Profound Medical Corp.

Equities

PRN

CA74319B5027

Press Releases

Filters